newsfilter
← Latest News
PR Newswire·

Stealth BioTherapeutics Completes a $25 Million Debt Financing with Horizon Technology Finance

BOSTON, Oct. 4, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, toda